CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells

Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity

(2014) M. B. Fuertes et al.   JOURNAL OF IMMUNOLOGY

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Inhibits Proximal TCR Signaling by Targeting ZAP-70

(2014) Zhangguo Chen et al.   JOURNAL OF IMMUNOLOGY

Protein Expression of Carcinoembryonic Antigen Cell Adhesion Molecules in Benign and Malignant Melanocytic Skin Lesions

(2009) Thilo Gambichler et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Systemic dysregulation of CEACAM1 in melanoma patients

(2009) Gal Markel et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Differential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus

(2009) J. Arapovic et al.   JOURNAL OF VIROLOGY

Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer

(2008) Sebastian Dango et al.   LUNG CANCER

On the role of CEACAM1 in cancer

(2008) Björn Öbrink   LUNG CANCER

Regulation of NKG2D ligands: a purposeful but delicate affair

(2008) Thomas Spies   NATURE IMMUNOLOGY

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer

(2008) Liqiang Xi et al.   NUCLEIC ACIDS RESEARCH